Pionyr Immunotherapeutics
San Francisco, US · Founded 2015 · Delaware corporation · 53 employees on LinkedIn · 6 known investors
Find your way into Pionyr Immunotherapeutics
149 people in our graph share verified history with the Pionyr Immunotherapeutics team — schools, employers, funds. One of them is your warm intro.
Henrik Jonesunlockedknows Steven James · together at Brown University (overlapped)
×2knows the team · via Exelixis
×2knows the team · via Ventus Therapeutics
×3knows the team · via Juvena Therapeutics
knows the team · via Brown University
knows the team · via Allakos Inc
Founders & leadership
Pionyr Immunotherapeutics was founded in 2015 by Matthew F. Krummel, Ph.D..
MF
Matthew F. Krummel, Ph.D.Founder
SP
Steven P. JamesinPresident & CEO2016–2023Steven P. James has spent over 35 years in pharmaceutical and biotechnology leadership, serving as CEO of Labrys Biologics, KAI Pharmaceuticals, and Pionyr Immunotherapeutics. He holds or has held board positions at multiple biotech companies including Allakos, Ventus Therapeutics, and Lyterian Therapeutics.
LC
Leon Chen, Ph.D.Named on SEC filing
JR
Joshua Resnick, M.D.Named on SEC filing
Board
MP
Investors · 6
Reported raises · per SEC filings
Form D private placements$45M disclosed across 2 rounds · 2017–2018
▶$7MraisedApr 2018 · 2 investors · Other Health CareRule 506(b)
▶$7MraisedApr 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carol GallagherDirector
- Joshua Resnick, M.D.Director
- Matthew F. Krummel, Ph.D.Director
- Leon Chen, Ph.D.Director
- Steven P. JamesExecutive Officer, Director, Promoter
- Michael PowellDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$38MraisedDec 2017 · 16 investors · Other Health CareRule 506(b)
▶$38MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leon Chen, Ph.D.Director
- Matthew F. Krummel, Ph.D.Director
- Michael PowellDirector
- Carol GallagherDirector
- Joshua Resnick, M.D.Director
- Steven P. JamesExecutive Officer, Director, Promoter
- Offering amount
- $62M
- Amount sold
- $38M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Pionyr Immunotherapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who founded Pionyr Immunotherapeutics?
- Pionyr Immunotherapeutics was founded by Matthew F. Krummel, Ph.D. in 2015.
- Who are Pionyr Immunotherapeutics's investors?
- Pionyr Immunotherapeutics's investors include Mission Bay Capital, Mission Biocapital, New Enterprise Associates (NEA), OUP (Osage University Partners), Sofinnova Ventures, Sofinnova Venture Partners.
- How much funding has Pionyr Immunotherapeutics raised?
- Pionyr Immunotherapeutics has disclosed $45M raised across 2 rounds.
- Where is Pionyr Immunotherapeutics headquartered?
- Pionyr Immunotherapeutics is headquartered in San Francisco, US.